Tofogliflozin Anhydrous

CHEMBL2110731 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

386.4 g/mol

LogP

1.5

Phase

4

Tofogliflozin anhydrous is the anhydrous crystalline form of tofogliflozin, a selective SGLT2 inhibitor used for type 2 diabetes management. See tofogliflozin for complete pharmacological details. The anhydrous form is used in specific oral solid dosage formulations to ensure pharmaceutical stability.

Moleküler Ağırlık

386,4000 g/mol

LogP

1,50

TPSA

99,40 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1

InChI

InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1

Molecular Formula

C22H26O6

HBD / HBA

4 / 6

Döndürülebilir Bağlar

4

Ağır Atomlar

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Tofogliflozin anhydrous is the anhydrous crystalline form of tofogliflozin, a selective SGLT2 inhibitor used for type 2 diabetes management. See tofogliflozin for complete pharmacological details. The anhydrous form is used in specific oral solid dosage formulations to ensure pharmaceutical stability.

Yes, Tofogliflozin Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110731. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 46908929. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Tofogliflozin Anhydrous PillFYI'da

Yapı

Hızlı Veriler

Formül: C22H26O6

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.